Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
But acquisition charges drag earnings into loss
The company posted revenue of Rs. 703 crore in Q4 FY26
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
Subscribe To Our Newsletter & Stay Updated
